Targeted protein degradation (TPD) is a therapeutic approach that leverages the cell's natural machinery to degrade targets instead of inhibiting them. This is accomplished by using mono- or bifunctional small molecules designed to induce the proximity of target proteins and E3 ubiquitin ligases, leading to ubiquitination and subsequent proteasome-dependent degradation of the target. One of the most significant attributes of the TPD approach is its proposed catalytic mechanism of action, which permits substoichiometric exposure to achieve the desired pharmacological effects.
View Article and Find Full Text PDFSuperconducting magnets based on Rare Earth Barium Copper Oxides (REBCO) offer transformative capabilities in the fields of fusion energy, high energy physics, and space exploration. A challenge shared by these applications is the limited lifetime of REBCO due to radiation damage sustained during operation. Here we present a new ion-beam facility that enables simultaneous cryogenic irradiation and in situ characterization of commercial REBCO tapes.
View Article and Find Full Text PDFMolecular glues (MGs) are monovalent small molecules that induce an interaction between proteins (native or non-native partners) by altering the protein-protein interaction (PPI) interface toward a higher-affinity state. Enhancing the PPI between a protein and E3 ubiquitin ligase can lead to degradation of the partnering protein. Over the past decade, retrospective studies of clinical drugs identified that immunomodulatory drugs (e.
View Article and Find Full Text PDFExsolution synthesizes self-assembled metal nanoparticle catalysts via phase precipitation. An overlooked aspect in this method thus far is how exsolution affects the host oxide surface chemistry and structure. Such information is critical as the oxide itself can also contribute to the overall catalytic activity.
View Article and Find Full Text PDF